Po Wen Wu
Directeur Général chez Polaris Pharmaceuticals, Inc.
Profil
Po Wen Wu is currently the President & Chief Executive Officer at Polaris Pharmaceuticals, Inc. and the Chairman & Chief Executive Officer at Designerx Pharmaceuticals, Inc. He is also the Chief Executive Officer & Director at DRX USA, DRX Chengdu, and TDW Pharmaceuticals, Inc. Additionally, he serves as a Director at DesigneRx Europe Ltd., DRX SHANGHAI, and DRX Hong Kong.
In the past, he was the President & Chief Executive Officer at Polaris Group, Inc. from 2011 to 2013 and the Chairman & General Manager at Polaris Group.
Dr. Wu holds a doctorate degree from the University of California, Berkeley.
Postes actifs de Po Wen Wu
| Sociétés | Poste | Début |
|---|---|---|
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Directeur Général | - |
| DesigneRx Europe Ltd. | Directeur/Membre du Conseil | - |
| Designerx Pharmaceuticals, Inc. | Directeur Général | - |
| DRX USA | Directeur Général | - |
| TDW Pharmaceuticals, Inc. | Directeur Général | - |
| DRX Chengdu | Directeur Général | - |
| DRX SHANGHAI | Directeur/Membre du Conseil | - |
| DRX Hong Kong | Directeur/Membre du Conseil | - |
Anciens postes connus de Po Wen Wu
| Sociétés | Poste | Fin |
|---|---|---|
Polaris Group, Inc.
 Polaris Group, Inc. Real Estate DevelopmentFinance Polaris Group is a sales, marketing and consulting firm with experience in bringing new residential real estate to market in the San Francisco Bay Area and Southern California. Polaris Group has three distinct divisions: Polaris Analytics, Polaris Marketing and Polaris Sales. From land acquisition, market research and entitlements, to architectural review, brand development and escrow coordination, Polaris Group analyzes each new home community and attempts to maximize builder opportunities. Their approach is based on constant evaluation of pricing trends, new product supply pipelines, construction pricing and market conditions. | President | 06/03/2013 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Po Wen Wu
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Entreprise privées | 9 |
|---|---|
Polaris Group, Inc.
Polaris Group, Inc. Real Estate DevelopmentFinance Polaris Group is a sales, marketing and consulting firm with experience in bringing new residential real estate to market in the San Francisco Bay Area and Southern California. Polaris Group has three distinct divisions: Polaris Analytics, Polaris Marketing and Polaris Sales. From land acquisition, market research and entitlements, to architectural review, brand development and escrow coordination, Polaris Group analyzes each new home community and attempts to maximize builder opportunities. Their approach is based on constant evaluation of pricing trends, new product supply pipelines, construction pricing and market conditions. | Finance |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| DesigneRx Europe Ltd. | |
| Designerx Pharmaceuticals, Inc. | |
| DRX USA | |
| TDW Pharmaceuticals, Inc. | |
| DRX Chengdu | |
| DRX SHANGHAI | |
| DRX Hong Kong |